Abstract

BackgroundPlants provide an alternative source to manage various human disorders due to diverse metabolites. Euphorbia dracunculoides of family Euphorbiaceae is used by local practitioners in rheumatism, epilepsy, edema, snake bite, warts and also possesses diuretic and purgative effects. The present study evaluated the antioxidant, anti-inflammatory and analgesic activities of various extracts of E. dracunculoides. Further, phytochemical constituents of the leading extracts were also investigated.MethodsDry powder of E. dracunculoides was extracted with n-hexane (EDH), acetone (EDA), ethanol (EDE), ethanol + water (1:1) (EDEW) and methanol (EDM) and screened for phytochemical classes, total phenolic (TPC) and flavonoid content (TFC). Antioxidant effects of the extracts were manifested by in vitro multidimensional assays. The anti-inflammatory and analgesic activities of the extracts were evaluated through carrageenan induced paw edema and hot plate test in rat. In addition, GC-MS analysis of EDH and HPLC-DAD analysis of EDEW was carried out to determine the presence of active constituents.ResultsQualitative analysis of various extracts of E. dracunculoides assured the existence of tannins and coumarins while presence of anthraquinones and anthocyanins was not traced in these extracts. Maximum quantity of TPC and TFC was recorded in EDEW followed by EDE. EDEW and EDE showed significant antioxidant activities with therapeutic potential against hydroxyl and phosphomolybdate radicals, β-carotene bleaching assay and in reducing of iron while moderate to low scavenging abilities were recorded for DPPH, nitric oxide and for iron chelation. During anti-inflammatory activity after 4 h of drug administration the 300 mg/kg body weight dose of EDH (68.660 ± 10.502 %) and EDE (51.384 ± 8.623 %) exhibited strong anti-inflammatory activity and reduced the carrageenan-induced paw edema in rat as compared to standard drug diclofenac sodium (78.823 ± 6.395 %). Treatment of rats with EDH (70.206 ± 5.445 %) and EDE (56.508 ± 6.363 %) after 90 min showed significant increase in percent latency time in hot plate test as compared to morphine (63.632 ± 5.449 %) treatment in rat. GC-MS analysis of EDH indicated the presence of 30 compounds predominantly of steroids and terpenoids. HPLC-DAD analysis against known standards established the presence of rutin, catechin, caffeic acid and myricetin in EDEW.ConclusionOur results suggest that presence of various polyphenolics, terpenoids and steroids render E. dracunculoides with therapeutic potential for oxidative stress and inflammation related disorders.

Highlights

  • Plants provide an alternative source to manage various human disorders due to diverse metabolites

  • Extraction yield, total phenolic and flavonoid content By using 100 g of dry powder of E. dracunculoides for extraction, the maximum yield 5462 mg powder was obtained for EDEW followed by 1703 mg (EDM), 1340 mg (EDA), 724 mg (EDE) and 592 mg (EDH)

  • Flavonoids were found to be rich in EDEW (7.57 ± 0.42 mg RE/g dry sample) followed by EDE (6.77 ± 0.31 mg RE/g dry sample), EDEW followed by mg (EDM) (4.84 ± 0.29 mg RE/g dry sample), EDA (4.52 ± 0.37 mg RE/g dry sample) and EDA (4.18 ± 0.25 mg RE/g dry sample)

Read more

Summary

Introduction

Plants provide an alternative source to manage various human disorders due to diverse metabolites. Plants derived chemicals are important source of clinical agents that have sedative, anti-depressant, antioxidant, antispasmodic, anxiolytic, anti-inflammatory, immunomodulatory, analgesic, anti-pyretic, and cardio protective activities [1]. This customary herbal medicinal system is deep rooted in their cultures and habitats and knowledge of home remedies is conveyed to their descendants as the time goes [2]. The indirectly acting antioxidants are very important in protecting body from deleterious effects of ROS/RNS This group comprised thousands of compounds involved in free radical scavenging and most of them are derived from dietary sources such as vegetables and fruits

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.